Conference Call with Fineotex Chemical Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals company Fineotex Chemical announced Q4FY25 & FY25 results Consolidated Q4FY25 Financial Highlights: Revenue from Operation for the quarter is Rs 11,978.54 Lakh Profit after tax (PAT) for the quarter ended is Rs 2,013.13 Lakh Gross Margin for the Quarter ended is 36.22% PAT Margin for the Quarter ended is 16.81% Consolidated FY25 Financial Highlights: Revenue from Operation is Rs 53,333.28 Lakh Profit after tax (PAT) for the year ended is Rs 10,920.82 Lakh. Gross Margin for the year ended is 38.57% PAT Margin for the year ended is 20.48% Standalone Q4FY25 Financial Highlights: Revenue from Operation for the year is Rs 43,922.21 Lakh Profit after tax (PAT) for the year ended is Rs 9,722.67 Lakh Gross Margin for the Quarter ended is 38.24% PAT Margin for the Quarter ended is 22.14% Standalone FY25 Financial Highlights: Revenue from Operation for the quarter is Rs 10,794.60 Lakh Profit after tax (PAT) for the quarter ended is Rs 1,944.05 Lakh Gross Margin for the Quarter ended is 35.30% PAT Margin for the Quarter ended is 18.01% Commenting on the overall performance of the Company, Sanjay Tibrewala, Executive Director, Fineotex Chemical said, “We ended FY25 on a stable footing, with steady performance in the textile chemicals segment and strong growth in newly diversified businesses. Despite a nuanced demand environment, our strategic direction remains clear, and we continue to execute with resilience and a long-term growth mindset. During the quarter, the textile chemicals segment remained stable, with sustained demand across key geographies. We added 30 new customers during fourth quarter, a testament to our expanding reach and trusted product performance. We also developed 15 new products, reinforcing our focus on innovation and our ability to respond swiftly to evolving customer requirements. While the FMCG, Cleaning & Hygiene segment witnessed a temporary softness in volumes, the underlying demand fundamentals remain intact, and we anticipate a pickup in the coming quarters.. Our new business verticals — Water Treatment and Oil & Gas — delivered strong performance, with a substantial increase in both volumes and value contribution backed by a robust and growing order pipeline. Further, we are undertaking focused capital expenditure, promotional and brand-building initiatives. These investments are aimed at enhancing production capabilities, strengthening market presence, and accelerating customer acquisition in these fast-growing business segments. These business lines are expected to play an increasingly significant role in our revenue mix in the coming years A major milestone during the year was the government approval of AquaStrike Premium, our biotechnology based mosquito control solution developed using Azadirachtin. This plant-based, sustainable innovation opens up growth opportunities in public health and institutional hygiene, both in India and emerging markets. Looking ahead, we are optimistic about the export environment. The India–UK Free Trade Agreement, is expected to improve market access, reduce trade barriers, and enhance our competitiveness in the UK and Europe, particularly for textile and specialty chemicals. To support our growth aspirations, we are pleased to report that our greenfield expansion is progressing as planned and will add 15,000 MTPA of capacity, increasing our total installed capacity to 1,20,000 MTPA expected to commence operations in Q2FY26. With a diversified product portfolio, strong demand pipeline, growing international reach, and a healthy balance sheet, we remain confident in our strategic roadmap and we are well-positioned to deliver consistent, long-term value to all stakeholders.” Result PDF